Peroxo heteroligand vanadates(V): Synthesis, spectra-structure relationships, and stability toward decomposition

  • Cirila Djordjevic
  • Nikola Vuletic
  • Myunghi Lee Renslo
  • Bruce C. Puryear
  • Ramin Alimard
Part of the Developments in Molecular and Cellular Biochemistry book series (DMCB, volume 16)


Effect of heteroligands (L) on the properties of vanadium peroxides was investigated by preparing a number of peroxo vanadium complexes, which were characterized by analysis, IR, UV/V and NMR spectra. X-ray structures for some were obtained. The vanadates(V) contain the cation M(I) = Na, K, NH4, Rb or Cs. Diperoxo complexes include M(I)[VO(O2)2 L], where L = dipyridyl, o-phenanthroline; M(I)3[VO(O2)2(C2O4)]; K2[(nicotinic acid){VO(O2)2}2]H2O;M(I)4[O{VO(O2)2}2cystine]2H2O; H4[O{VO(O2)2(adenine)2)2]2H2O; and K2H2[O{VO(O2)2(adenosine)}2]2H2O. Monoperoxo vanadates(V) correspond to the formula M(I)2[VO(O2)L]2 for L = citrate and malate; M(I)2[VO(O2)L] for L = nitrilotriacetate; M(I)[VO(O2)L] for L = iminodiacetate, tartrate and EDTA; and [HVO2(O2)(adenosine)]2H2O. Syntheses of these heteroligand peroxovanadium compounds are sensitive to pH, temperature and the concentration of the components. The stability towards decomposition in solid state, mother-liquid and pure water solutions depends upon the heteroligand. Characteristic (V=0) and (O-O) stretching frequency bands in IR can be correlated with the corresponding bond lengths and the [peroxo∼V(V)] charge transfer bands in UV/V spectra. Intramolecular one-electron transfer in peroxo vanadates(V) can trigger the generation of radicals, and its dependency upon the nature of the heteroligand is discussed.

Key words

vanadium peroxo complexes peroxo aminopolycarboxylato vanadates peroxo cystine vanadate peroxo adenine vanadate peroxo adenosine vanadate peroxo-vanadium charge transfer bands 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shaver A, Ng TB, Hall DA, Lum BS, Posner I: Insulin-mimetic peroxovanadium complexes: Preparation and structure of potassium oxodiperoxo (pyridine-2-carboxylato) vandate(V), K2[VO(O2)2− (C5H4NCOO)]·2H2O, and potassium oxodiperoxo (3-hydroxy-pyridine-2-carboxylato) vanadate(V), K2[VO(O2)2(OHC5H3NCOO)] ·3H2O, and their reactions with cysteine. Inorg Chem 32: 3109–3113, 1993CrossRefGoogle Scholar
  2. 2.
    Posner BI, Faure R, Burgess JW, Bevan AP, Lachance D, Zhang-Sun G, Fantus IG, Ng JB, Hall DA, Soo Lum B, Shaver A: Peroxovanadium Compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J Biol Chem 269: 4596–4604, 1994PubMedGoogle Scholar
  3. 3.
    Vuletic N, Djordjevic C: Oxoperoxovanadate(V) complexes with bidentate ligands. J Chem Soc Dalton: 1137–1141, 1973Google Scholar
  4. 4.
    Djordjevic C: Heteroligand peroxo transition metal complexes, Chem Br 18: 554–557, 1982Google Scholar
  5. 5.
    Djordjevic C, Craig SA: A polymeric peroxoheteroligandvanadate(V). Synthesis, spectra and structure of M(I)[VO(O2)(C4H5O4N)]. Inorg Chem 24: 1281–1283, 1985CrossRefGoogle Scholar
  6. 6.
    Djordjevic C, Puryear BC, Vuletic N, Abelt CJ, Sheffield SJ: Preparation, spectroscopic properties and characterization of novel peroxo complexes of vanadium(V) and molybdenum(VI) with nicotinic acid and nicotinic acid N-oxide. Inorg Chem 27: 2926–2932, 1988CrossRefGoogle Scholar
  7. 7.
    Djordjevic C, Lee M, Sinn E: Oxoperoxo(citrato)- and dioxo(citrato) vanadates(V): synthesis, spectra and structure of a hydroxyl oxygen bridgeddimer, K2[VO(O2)(C6H6O7)2]22H2O. Inorg Chem 28: 719–723, 1989CrossRefGoogle Scholar
  8. 8.
    Djordjevic C: Peroxo heteroligand complexes of vanadium(V) and molybdenum(VI): Analogy and differences. 29th ICCC, Lausanne, Switzerland, Abstract, p. 108, 1992Google Scholar
  9. 9.
    Djordjevic C, Vuletic N, Puryear B.C: Vanadium(V) and molyb-denum(VI) peroxo complexes with adenine and adenosine, and the choice of donor atoms in peroxo heteroligand spheres. J Inorg Biochem 51: 308, 1993CrossRefGoogle Scholar
  10. 10.
    Djordjevic C, Wilkins P.L, Sinn E, Butcher R.J: Peroxoaminopoly carboxylatovanadate(V) of an unusual low toxicity: synthesis and structure of the very stable K2[VO(O2)(C6H6NO6)]2H2O. Inorg Chim Acta 230: 241–244, 1995CrossRefGoogle Scholar
  11. 11.
    Djordjevic C, Lee-Renslo M, Sinn E: Peroxo malato vanadates(V): synthesis, spectra, and structure of (NH4)2[VO(O2)(C4H4O5)]22H2O dimer with a rhomboidal V202(hydroxyl) bridging core. Inorg Chim Acta 233: 97–102, 1995CrossRefGoogle Scholar
  12. 12.
    Djordjevic C: Antitumor Activity of vanadium compounds. In: H. Sigel, A. Sigel (eds.). Metal ions in biological systems, Vol. 31. Vanadium and its role for life. Marcel Dekker, New York, 1995Google Scholar
  13. 13.
    Conte V, Di Furia F, Moro S: 51V-NMR investigationon the formation of peroxo vanadium complexes in aqueous solution: some novel obeservations. J Molec Catal, 94: 323–333, 1994CrossRefGoogle Scholar
  14. 14.
    Jaswal S J, Tracey AS: Reactions of mono- and diperoxo vanadates with peptides containing fiinctionalized side chains. J Am Chem Soc 115: 5600–5607, 1993CrossRefGoogle Scholar
  15. 15.
    Chasteen N.D. (ed.): Vanadium in biological systems. Kluwer Academic Publishers, Dordrecht, 1990Google Scholar
  16. 16.
    Wever R, Kustin K: Vanadium: a biologically relevant element. Adv. Inorg. Chem. 35: 81–115, 1990CrossRefGoogle Scholar
  17. 17.
    Nechay BR, Nanninga LB, Nechey PSE, Post RL, Grantham JJ, Macara IG, Kubena LF, Phillips TD, Nielsen FH: Role of vanadium in biology, Feder Proc 45: 123–132, 1966Google Scholar
  18. 18.
    Djordjevic C, Wampler G.L: Antitumor activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium, J. Inorg. Biochem. 25: 51–55, 1985PubMedCrossRefGoogle Scholar
  19. 19.
    Begin D, Einstein FWB, Field J: An assymmetrically coordinated diperoxo compound. Crystal structure of K3[VO(O2)2(C2O4)]H2O. Inorg Chem 14: 1785–1790, 1975CrossRefGoogle Scholar
  20. 20.
    Stomberg R, Olson S, Svenson LB: The crystal structure of ammonium μ-oxo bis(oxodiperoxovanadate)(4-),(NH4)4[O{VO(O2)2}2]. A Refinement. Acta Chem. Scand. A 38: 653–656, 1984CrossRefGoogle Scholar
  21. 21.
    Stomberg R, Szentivanyi H: The crystal structure of 2,2′-Bipyridinium(l+) (2,2′-Bipyridine)-oxodiperoxovanadate(l-)(3+x)-(2-x)H2O, x = 0.4, at −100°C. Acta Chem Scand A38: 121–128, 1984CrossRefGoogle Scholar
  22. 22.
    Chasteen ND, Grady JK, Holloway CE: Characterization of the binding, kinetics and redox stability of vanadium(IV) and vanadium(V) protein complexes in serum. Inorg Chem 25: 2754–2760, 1986CrossRefGoogle Scholar
  23. 23.
    Bonchio M, Conte V, Di Furia F, Modena G, Moro S: Nature of the radical intermediates in the decomposition of peroxovanadium species in protic and aprotic media. Inorg Chem 33: 1631–1637, 1994CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1995

Authors and Affiliations

  • Cirila Djordjevic
    • 1
  • Nikola Vuletic
    • 2
  • Myunghi Lee Renslo
    • 3
  • Bruce C. Puryear
    • 4
  • Ramin Alimard
    • 5
  1. 1.Department of ChemistryThe College of William and MaryWilliamsburgUSA
  2. 2.Institute of TobaccoZagrebCroatia
  3. 3.Kaiser M. D. AssociatedLos AngelesUSA
  4. 4.Department of Anesthesiology, College of MedicineUniversity of FloridaGainesvilleUSA
  5. 5.Medical College of VirginiaVCURichmondUSA

Personalised recommendations